Solid Biosciences Inc.
SLDB
$6.83
-$0.01-0.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.28M | -42.60M | -32.73M | -25.07M | -24.30M |
| Total Depreciation and Amortization | 407.00K | 488.00K | 405.00K | 1.24M | 327.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.23M | 10.34M | 5.78M | 2.29M | 1.64M |
| Change in Net Operating Assets | 1.79M | 2.13M | 2.84M | 78.00K | -2.85M |
| Cash from Operations | -31.85M | -29.65M | -23.71M | -21.47M | -25.19M |
| Capital Expenditure | -126.00K | -204.00K | -15.00K | -286.00K | -149.00K |
| Sale of Property, Plant, and Equipment | -- | 5.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.34M | 38.77M | -10.97M | -4.89M | -38.34M |
| Cash from Investing | -27.46M | 38.57M | -10.99M | -5.18M | -38.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -135.00K | -128.00K | -120.00K | -225.00K | -- |
| Issuance of Common Stock | 189.88M | 7.07M | 3.38M | 5.51M | 112.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | 0.00 | 0.00 | -286.00K | -4.83M |
| Cash from Financing | 189.73M | 6.94M | 3.26M | 5.00M | 107.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.42M | 15.86M | -31.44M | -21.64M | 43.56M |